Neuberger Berman High Yield Strategies Fund Announces $7.44/share Purchase
ByAinvest
Friday, May 30, 2025 7:21 pm ET1min read
HCSG--
NHS is a closed-ended fixed income mutual fund that invests in high yield debt securities across various sectors, including auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. The fund, managed by Neuberger Berman Investment Advisers LLC, was launched on July 28, 2003 [3].
The acquisition of shares by Kocinski, who is a key figure in the fund's management, indicates a level of confidence in the fund's prospects. This aligns with the broader trend of insider buying, as seen in other recent transactions involving high-profile insiders such as Jeffrey Yurcisin, President & CEO of Grove Collaborative Holdings Inc., who purchased 15,000 shares of his company on May 23, 2025 [2].
The stock's recent performance has been mixed, with shares crossing below their 200-day moving average on May 28, 2025. However, the fund's dividend policy remains attractive, with a monthly dividend of $0.0905, representing a $1.09 annualized dividend and a dividend yield of 14.72% [4]. This suggests that the fund continues to offer a compelling investment proposition despite recent market fluctuations.
References:
[1] https://www.streetinsider.com/SEC+Filings/Form+4+Neuberger+Berman+High+For%3A+May+29+Filed+by%3A+Kocinski+Chris/24879207.html
[2] https://www.gurufocus.com/news/2890394/insider-buying-jeffrey-yurcisin-acquires-15000-shares-of-grove-collaborative-holdings-inc-grov
[3] https://finance.yahoo.com/quote/NHS/
[4] https://www.marketbeat.com/instant-alerts/neuberger-berman-high-yield-strategies-fund-nyseamericannhs-shares-pass-below-200-day-moving-average-heres-what-happened-2025-05-28/
NBXG--
NHS--
Neuberger Berman High Yield Strategies Fund Inc. (NHS) has recently disclosed that Christopher Kocinski has made a significant investment in the company. On May 29, 2025, Kocinski acquired 15,000 shares at a per-share price of $7.44.
On May 29, 2025, Christopher Kocinski, a director and portfolio manager at Neuberger Berman Investment Advisers LLC, acquired 15,000 shares of Neuberger Berman High Yield Strategies Fund Inc. (NHS) at a per-share price of $7.44 [1]. This transaction was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission (SEC).NHS is a closed-ended fixed income mutual fund that invests in high yield debt securities across various sectors, including auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. The fund, managed by Neuberger Berman Investment Advisers LLC, was launched on July 28, 2003 [3].
The acquisition of shares by Kocinski, who is a key figure in the fund's management, indicates a level of confidence in the fund's prospects. This aligns with the broader trend of insider buying, as seen in other recent transactions involving high-profile insiders such as Jeffrey Yurcisin, President & CEO of Grove Collaborative Holdings Inc., who purchased 15,000 shares of his company on May 23, 2025 [2].
The stock's recent performance has been mixed, with shares crossing below their 200-day moving average on May 28, 2025. However, the fund's dividend policy remains attractive, with a monthly dividend of $0.0905, representing a $1.09 annualized dividend and a dividend yield of 14.72% [4]. This suggests that the fund continues to offer a compelling investment proposition despite recent market fluctuations.
References:
[1] https://www.streetinsider.com/SEC+Filings/Form+4+Neuberger+Berman+High+For%3A+May+29+Filed+by%3A+Kocinski+Chris/24879207.html
[2] https://www.gurufocus.com/news/2890394/insider-buying-jeffrey-yurcisin-acquires-15000-shares-of-grove-collaborative-holdings-inc-grov
[3] https://finance.yahoo.com/quote/NHS/
[4] https://www.marketbeat.com/instant-alerts/neuberger-berman-high-yield-strategies-fund-nyseamericannhs-shares-pass-below-200-day-moving-average-heres-what-happened-2025-05-28/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet